Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Linde
LIN
|
$588M |
| 2 |
Apple
AAPL
|
$574M |
| 3 |
Illumina
ILMN
|
$398M |
| 4 |
argenx
ARGX
|
$306M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
$250M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$600M |
| 2 |
AbbVie
ABBV
|
$323M |
| 3 |
Sherwin-Williams
SHW
|
$309M |
| 4 |
Atlassian
TEAM
|
$250M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$241M |
Sector Composition
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.43% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Driven Brands
DRVN
$3.11B
| $64.5M | 0.04% |
2,129,029
+49,479
| +2% | +$1.5M |
|
|
AGTI
327
DELISTED
Agiliti, Inc.
AGTI
| $64.2M | 0.04% |
4,017,437
-1,365,203
| -25% | -$21.8M |
|
328
Seres Therapeutics
MCRB
$169M
| $64.1M | 0.04% |
565,041
+2,626
| +0.5% | +$298K |
|
329
Under Armour Class C
UA
$2.13B
| $63.3M | 0.04% |
7,419,022
+2,612,130
| +54% | +$22.3M |
|
|
IMGN
330
DELISTED
Immunogen Inc
IMGN
| $63.2M | 0.04% |
16,450,081
+13,302,505
| +423% | +$51.1M |
|
|
AVDL
331
Avadel Pharmaceuticals
AVDL
$1.53B
| $62.5M | 0.04% |
6,826,787
+5,619,257
| +465% | +$51.4M |
|
332
CCC Intelligent Solutions
CCCS
$6.4B
| $62.4M | 0.04% |
6,958,175
+601,543
| +9% | +$5.4M |
|
333
Zai Lab
ZLAB
$3.42B
| $62.2M | 0.04% |
1,871,042
+276,417
| +17% | +$9.19M |
|
334
Brown-Forman Class B
BF.B
$13.7B
| $61.9M | 0.04% |
962,445
+322,597
| +50% | +$20.7M |
|
335
Cardinal Health
CAH
$35.7B
| $61.1M | 0.04% |
809,323
+205,321
| +34% | +$15.5M |
|
336
Thor Industries
THO
$5.94B
| $61M | 0.04% |
766,013
-103,797
| -12% | -$8.27M |
|
337
Entegris
ENTG
$12.4B
| $60.8M | 0.04% |
741,794
-60,062
| -7% | -$4.93M |
|
338
S&P Global
SPGI
$164B
| $60.7M | 0.04% |
176,276
+271
| +0.2% | +$93.4K |
|
339
Fox Class B
FOX
$24.9B
| $60.7M | 0.04% |
1,939,162
+888,625
| +85% | +$27.8M |
|
340
UBS Group
UBS
$128B
| $60.3M | 0.04% |
2,851,140
+791,312
| +38% | +$16.7M |
|
341
Alnylam Pharmaceuticals
ALNY
$59.4B
| $59.9M | 0.04% |
298,843
-166,545
| -36% | -$33.4M |
|
342
MACOM Technology Solutions
MTSI
$9.67B
| $59.7M | 0.04% |
843,376
+833,648
| +8,570% | +$59.1M |
|
343
iRhythm Technologies
IRTC
$5.82B
| $59.3M | 0.04% |
478,419
+8,603
| +2% | +$1.07M |
|
344
First Interstate BancSystem
FIBK
$3.41B
| $59.1M | 0.04% |
1,978,718
+106,637
| +6% | +$3.18M |
|
345
Equity Lifestyle Properties
ELS
$12B
| $58.9M | 0.04% |
877,571
-2,461
| -0.3% | -$165K |
|
346
Labcorp
LH
$23.2B
| $58.8M | 0.04% |
298,235
-51,922
| -15% | -$10.2M |
|
347
Innospec
IOSP
$2.13B
| $57.9M | 0.04% |
564,177
+125,785
| +29% | +$12.9M |
|
348
Descartes Systems
DSGX
$9.26B
| $57.7M | 0.04% |
716,296
-44,506
| -6% | -$3.59M |
|
|
SWAV
349
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $57.7M | 0.04% |
266,214
+259,754
| +4,021% | +$56.3M |
|
350
State Street
STT
$32B
| $57.7M | 0.04% |
762,362
-53,860
| -7% | -$4.08M |
|